Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents
Open accessThe DOI matches its OpenAlex record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Rosmarinus officinalis L. (Rosemary) has been long claimed to have hypogylcemic-hypolipidemic dual effects in folkloric medicine. In an effort to explain rosemary's claimed benefits, numerous published studies have investigated an array of pharmacologic activities of the plant including anti-inflammatory, anticarcinogenic and metabolic effects. The question remained, however, as how rosemary would target both plasma lipids and glucose levels simultaneously. A newer mechanism has been suggested, in which targeting the hormone sensitive lipase (HSL) would be the common link between the two metabolic effects. In fact, HSL has been extensively studied for its effects on the metabolic switch between glucose and free fatty acids (FFAs) as an energy source. The current manuscript summarizes a significant amount of work that was undertaken to identify plant species native to Jordan with potential HSL and pancreatic lipase (PL) inhibitory activities. Our results demonstrated in vitroinhibitory effects of R. officnalis on both HSL and PL in a dose dependent manner. Interestingly, the rosemary extract had an IC50 for PL that was several fold lower than the IC50 for HSL, indicating a higher affinity to the former enzyme (13.8 and 95.2 μg/mL for PL and HSL, respectively). In addition, we have compared the inhibitory activities of purified constituents found in rosemary to the parent plant [rosmarinic acid (RA), chlorogenic acid (CA), caffeic acid (CaA) and gallic acid (GA)]. Our results showed that all the tested compounds (RA, CA, CaA, and GA) were able to inhibit the PL and HSL activities in a dose dependent manner, but with different potencies. PL and HSL IC50 values were calculated for each compound and GA was found to be the most potent (IC50 10.1 and 14.5 for PL and HSL, respectively). Further work is necessary to determine whether our in vitro findings would correlate with the in vivo effects. Nonetheless, our results are a first step in fully understanding the long claimed hypoglycemic-hypolipidemic dual effects of rosemary. Simultaneous targeting of both HSL and PL is likely to open the door for a new era in our continuous battle against DM type 2 and its cardiovascular complications. Currently, we are working on identifying the most active constituents of the plant to evaluate a structure-activity relationship which would pave the road for future therapeutic use. Key words: Rosmarinus officinalis, Rosemary, obesity, diabetes mellitus, pancreatic lipase, hormone sensitive lipase, phenolic compounds, rosmarinic acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237
Pancreatic lipase inhibitors from natural sources: Unexplored potential
Birari, R. B., & Bhutani, K. K. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.024 · Cited by 871
Kraemer, F. B., & Shen, W.-J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200009-jlr200 · Cited by 511
Rababah, T. M., Hettiarachchy, N. S., & Horax, R. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf049645z · Cited by 279
Inhibition of Protein Glycation by Extracts of Culinary Herbs and Spices
Dearlove, R. P., Greenspan, P., Hartle, D. K., Swanson, R. B., & Hargrove, J. L. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2007.536 · Cited by 157 · cited 1×
“…choleretic, diuretic, hypoglycemic, anti-inflammatory, antimicrobial, anticarcinogenic, hepatotonic and hypolipidimic activities of rosemary (Dearlove et al., 2008; Erenmemisoglu et al., 1997; Gutierrrez et al., 2010; Harach et al., 2010; Koga et al., 2006; Nabekura et al., 2010;…”
Background
Cited by
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13354 · Cited by 604
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14752 · Cited by 505
Polyphenolic Compounds as Pancreatic Lipase Inhibitors
Buchholz, T., & Melzig, M. (2015) · Planta Medica · doi:10.1055/s-0035-1546173 · Cited by 301
An Overview of Hormone-Sensitive Lipase (HSL)
Althaher, A. R. (2022) · The Scientific World Journal · doi:10.1155/2022/1964684 · Cited by 129
Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives
Naimi, M., Vlavcheski, F., Shamshoum, H., & Tsiani, E. (2017) · Nutrients · doi:10.3390/nu9090968 · Cited by 119
“Pure RA was also shown to inhibit HSL and PL in a dose dependent manner although the degree of inhibition was lower than the whole extract [33].”
Background
Metadata
- Authors
- Bustanji, Y. K., Issa, A., Mohammad, M., Hudaib, M., Tawah, K., AlKhatib, H. S., Almasri, I. M., & Alkhalidi, B. A.
- Venue
- Journal of Medicinal Plants Research
- Publisher
- Academic Journals
- Published
- 2010-11-04
- Volume
- 4
- Issue
- 21
- Pages
- 2235-2242
- ISSN
- 1996-0875 (ISSN-L)
- OpenAlex
- W2138898558
- Cited by
- 124
- References
- 5
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.